The downard move runs counter to the expectation that investors would seek shelter in safe haven investments like precious metals.
The divestiture will help the company's growing focus closer to its Colorado headquarters, it says.
CordenPharma Colorado is leasing 5505 Central, a newly completed, purpose-built peptide development lab at Flatiron Park in Boulder (US). Photo credit: CordenPharma Photo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results